Information  X 
Enter a valid email address

Reed Elsevier PLC (REL)

  Print      Mail a friend       Annual reports

Tuesday 07 April, 2015

Reed Elsevier PLC

Director/PDMR Shareholdings

RNS Number : 5468J
Reed Elsevier PLC
07 April 2015
 



 

 

ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV

 

7 April 2015

 

 

Director/PDMR Shareholdings

 

Reed Elsevier PLC and Reed Elsevier NV announce the following transactions in their securities by their Directors and PDMRs:

 

1.  RELX Group plc LTIP (Long-Term Incentive Plan 2013)

 

On 2 April 2015, the performance shares set out below were granted in accordance with the LTIP rules.

 


No. of Reed Elsevier PLC performance ordinary shares awarded

No. of Reed Elsevier NV performance ordinary shares awarded

Date of vesting of performance shares

Director




Erik Engstrom

119,771

82,158

2018

Nick Luff

56,423

38,704

2018





PDMR




Ian Fraser

27,825

19,086

2018

Henry Udow

30,381

20,840

2018

 

Vesting of these awards is subject to achievement of performance conditions.

 

 

2.  RELX Group plc BIP (Bonus Investment Plan 2010)

 

On 2 April 2015, the conditional matching share awards set out below were granted in accordance with the BIP rules.

 


No. of Reed Elsevier PLC

conditional matching ordinary shares awarded

No. of Reed Elsevier NV

conditional matching ordinary shares awarded

No. of Reed Elsevier PLC

conditional matching ADRs awarded

No. of Reed Elsevier NV

conditional matching ADRs awarded

Date of vesting of conditional matching shares/ADRs

Director






Erik Engstrom

-

-

-

31,732

2018

Nick Luff

28,187

19,194

-

-

2018







PDMR






Ian Fraser

38,493

-

-

-

2018

Henry Udow

21,014

7,155

2,540

-

2018

 

Note: Each Reed Elsevier PLC ADR represents 4 Reed Elsevier PLC ordinary shares and each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares. 

 

Vesting of these awards is subject to achievement of performance conditions.

 

 

3.  RELX Group plc ESOS (Executive Share Option Scheme 2013)

 

On 2 April 2015, the market price options and conditional share awards set out below were granted in accordance with the ESOS rules.

 


No. of Reed Elsevier PLC ordinary shares under option granted with an exercise price of £11.52 per share

No. of Reed Elsevier NV ordinary shares under option

 granted with an exercise price of €23.075 per share

No. of Reed Elsevier PLC conditional ordinary shares awarded

No. of Reed Elsevier NV conditional ordinary shares awarded

Director





Erik Engstrom

119,771

82,158

-

-

Nick Luff

56,423

38,704

-

-






PDMR





Ian Fraser

10,702

7,341

2,140

1,468

Henry Udow

11,685

8,015

2,337

1,603

 

Note: The options are exercisable between 2018 and 2025, and the conditional share awards vest in 2018.

 

Vesting of options awarded to Directors is subject to achievement of performance conditions.

 

The conditional share awards under ESOS were granted pursuant to elections by these PDMRs to receive half of their 2015 ESOS award in the form of conditional shares.

 

 

4.  RELX Group plc Executive Share Option Scheme:  Exercise of options and sale of shares

 

On 2 April 2015, Erik Engstrom exercised options granted on 5 May 2011 to acquire 139,146 Reed Elsevier PLC ordinary shares and 92,953 Reed Elsevier NV ordinary shares at option prices per share of £5.39 and €8.969 respectively.  All of the ordinary shares acquired on exercise were sold at the prices shown below.

 

 

No. of Reed Elsevier PLC ordinary shares

No. of Reed Elsevier NV ordinary shares

Sale price

2,782

-

£11.55

136,364

-

£11.5189

-

1,859

€23.0557

-

91,094

€23.0087

 

 

 

Following these transactions, the current interests of Erik Engstrom and Nick Luff in the share capital of Reed Elsevier PLC and Reed Elsevier NV are:

 


No. of Reed Elsevier PLC ordinary shares

No. of Reed Elsevier NV ordinary shares

Director



Erik Engstrom

127,040

521,556

Nick Luff

67,534

47,616

 

 

 

- ENDS -

 

 

 

Enquiries

 

Paul Abrahams (Media)                                     
+44 20 7166 5724                                             

 
Colin Tennant (Investors)

+44 20 7166 5751


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFSRSEIDIIE

a d v e r t i s e m e n t